title: Clinical impact of stent construction and design in percutaneous coronary intervention.
abstract: Convincing end point data demonstrating the anatomic and clinical superiority of stent placement compared with balloon angioplasty together with significant improvement in stenting technique and poststent management have resulted in an explosion in stenting procedures and the emergence of more than 40 stent types with disparate designs and material composition in clinical use. Structural nuances in design, composition, and coating of different stent models, however, have been shown to have a major influence on the risk of stent thrombosis, the degree of vessel wall injury, and subsequent intimal proliferation in the experimental model. There is now substantial amount of evidence to indicate that the same relationship between stent structural characteristics and vessel wall outcome holds true in humans. This article provides an up-to-date overview of the clinical impact of stent construction and design, including the clinical performance of drug-eluting stents.
authors.affiliation: National Heart Centre, Singapore, Singapore. LAU_Kean_Wah@nhc.com.sg
authors.forename: Kean-Wah
authors.initials: KW
authors.lastname: Lau
authors.forename: Koon-Hou
authors.initials: KH
authors.lastname: Mak
authors.forename: Jui-Sung
authors.initials: JS
authors.lastname: Hung
authors.forename: Ulrich
authors.initials: U
authors.lastname: Sigwart
mesh_terms: D001672:Biocompatible Materials; D003327:Coronary Disease / Q000601:surgery*; D023903:Coronary Restenosis / Q000517:prevention & control; D016503:Drug Delivery Systems; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D011474:Prosthesis Design; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects / Q000145:classification
chemical_list: D001672:Biocompatible Materials; D017239:Paclitaxel; D020123:Sirolimus